Immediate Impact
13 standout
Citing Papers
HER2-targeted therapies in cancer: a systematic review
2024 Standout
Advances in targeting histone deacetylase for treatment of solid tumors
2024 Standout
Works of Debora De Bartolo being referenced
HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment
2022
Evolution of HER2-low expression from primary to recurrent breast cancer
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Debora De Bartolo | 196 | 28 | 101 | 116 | 10 | 257 | |
| Neil Atkey | 179 | 39 | 67 | 82 | 14 | 283 | |
| Leila Russo | 243 | 15 | 135 | 113 | 13 | 323 | |
| V. Visokai | 166 | 51 | 87 | 121 | 11 | 297 | |
| Patricia DeFusco | 164 | 12 | 96 | 102 | 15 | 322 | |
| Dominique J P van Uden | 140 | 37 | 131 | 43 | 14 | 263 | |
| S Kirk | 215 | 81 | 131 | 75 | 11 | 321 | |
| Ahmed M. Amer | 122 | 40 | 34 | 144 | 15 | 299 | |
| S Hales | 131 | 43 | 87 | 73 | 7 | 257 | |
| Emarjola Bako | 278 | 14 | 52 | 81 | 13 | 288 | |
| Eileen Wrabel | 214 | 7 | 71 | 139 | 13 | 267 |
All Works
Loading papers...